Two Sigma Investments, LP Puma Biotechnology, Inc. Transaction History

Two Sigma Investments, LP

  • $41.6 Billion
  • Q4 2024

A detailed history of Two Sigma Investments, LP transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 181,471 shares of PBYI stock, worth $617,001. This represents 0.0% of its overall portfolio holdings.

Number of Shares
181,471
Previous 49,555 266.2%
Holding current value
$617,001
Previous $126,000 338.89%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$2.42 - $3.39 $319,236 - $447,195
131,916 Added 266.2%
181,471 $553,000
Q3 2024

Nov 14, 2024
BUY
$2.25 - $4.03 $34,328 - $61,485
15,257 Added 44.48%
49,555 $126,000
Q2 2024

Aug 14, 2024
SELL
$2.92 - $5.83 $138,396 - $276,318
-47,396 Reduced 58.02%
34,298 $111,000
Q1 2024

May 15, 2024
SELL
$4.29 - $7.4 $572,620 - $987,737
-133,478 Reduced 62.03%
81,694 $432,000
Q4 2023

Feb 14, 2024
BUY
$2.23 - $4.49 $239,577 - $482,378
107,434 Added 99.72%
215,172 $931,000
Q3 2023

Nov 14, 2023
BUY
$2.63 - $4.09 $4,378 - $6,809
1,665 Added 1.57%
107,738 $283,000
Q2 2023

Aug 14, 2023
SELL
$2.6 - $3.58 $265,397 - $365,432
-102,076 Reduced 49.04%
106,073 $374,000
Q1 2023

May 15, 2023
SELL
$2.21 - $4.82 $167,520 - $365,360
-75,801 Reduced 26.7%
208,149 $643,000
Q4 2022

Feb 14, 2023
BUY
$2.12 - $5.08 $424,727 - $1.02 Million
200,343 Added 239.62%
283,950 $1.2 Million
Q3 2022

Nov 14, 2022
SELL
$2.27 - $3.84 $160,255 - $271,092
-70,597 Reduced 45.78%
83,607 $198,000
Q2 2022

Aug 15, 2022
SELL
$1.64 - $3.3 $20,085 - $40,415
-12,247 Reduced 7.36%
154,204 $439,000
Q1 2022

May 16, 2022
BUY
$2.13 - $3.24 $354,540 - $539,301
166,451 New
166,451 $479,000
Q4 2021

Feb 14, 2022
SELL
$2.85 - $6.58 $45,372 - $104,753
-15,920 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$6.63 - $9.39 $262,799 - $372,200
-39,638 Reduced 71.35%
15,920 $112,000
Q2 2021

Aug 16, 2021
BUY
$8.98 - $11.6 $498,910 - $644,472
55,558 New
55,558 $510,000
Q3 2019

Nov 14, 2019
SELL
$8.75 - $12.85 $2.04 Million - $2.99 Million
-232,772 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$12.3 - $35.76 $1.29 Million - $3.76 Million
105,115 Added 82.34%
232,772 $2.96 Million
Q1 2019

May 15, 2019
BUY
$20.77 - $42.37 $67,398 - $137,490
3,245 Added 2.61%
127,657 $4.95 Million
Q4 2018

Feb 14, 2019
BUY
$20.07 - $46.7 $2.5 Million - $5.81 Million
124,412 New
124,412 $2.53 Million
Q4 2017

Feb 14, 2018
SELL
$93.85 - $132.45 $167,616 - $236,555
-1,786 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
$72.0 - $119.75 $128,592 - $213,873
1,786
1,786 $214,000

Others Institutions Holding PBYI

# of Institutions
110
Shares Held
28.3M
Call Options Held
27.9K
Put Options Held
3.4K
View Full List

About PUMA BIOTECHNOLOGY, INC.

PBYI Quotes by TradingView
  • Ticker PBYI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,556,000
  • Market Cap $155M
  • Description
  • Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...
More about PBYI
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email